recurrent primary peritoneal clear cell adenocarcinoma

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +14 more
  • Biopsy
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 28, 2023

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma Trial in

Recruiting
  • Fallopian Tube Mucinous Adenocarcinoma
  • +49 more
  • Cediranib Maleate
  • +5 more
  • Anchorage, Alaska
  • +373 more
Aug 17, 2022

Recurrent Fallopian Tube Clear Cell Adenocarcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Platinum-Resistant

Recruiting
  • Recurrent Fallopian Tube Clear Cell Adenocarcinoma
  • +5 more
  • Etigilimab
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 22, 2021